In addition to oncogenic mutations, p53, a common tumor suppressor gene, is often mutated or deleted in approximately 50% of human cancers, which leads to aberrant metabolic reprogramming in cancer cells (Kruiswijk et al, 2015). Here, TP53 is linked to cancer.